We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vertiv
VRT
$101B
| $78.8M | 0.09% |
315,100
-83,507
| -21% | -$18.5M |
|
|
AXON
227
Axon Enterprise
AXON
$46.4B
| $78.3M | 0.09% |
184,412
-34,097
| -16% | -$17.7M |
|
228
Mondelez International
MDLZ
$78.8B
| $78.1M | 0.09% |
1,355,559
+203,528
| +18% | +$11.8M |
|
229
Xenon Pharmaceuticals
XENE
$6.02B
| $78M | 0.09% |
1,342,028
+281,807
| +27% | +$13M |
|
230
Procept Biorobotics
PRCT
$1.05B
| $77.3M | 0.09% |
3,089,378
-5,271
| -0.2% | -$149K |
|
231
Simon Property Group
SPG
$74.3B
| $76.8M | 0.09% |
411,845
-174,629
| -30% | -$33.3M |
|
232
Insmed
INSM
$21.3B
| $76.5M | 0.09% |
467,753
+139,425
| +42% | +$21.4M |
|
233
AT&T
T
$162B
| $76.4M | 0.09% |
2,643,053
-855,623
| -24% | -$22.9M |
|
234
Spotify
SPOT
$100B
| $74.8M | 0.09% |
154,154
-20,343
| -12% | -$10.2M |
|
235
Toronto Dominion Bank
TD
$200B
| $73.8M | 0.09% |
790,058
+533,690
| +208% | +$50.8M |
|
236
PTC
PTC
$16.2B
| $73.5M | 0.09% |
515,905
-19,064
| -4% | -$3.01M |
|
237
Veeva Systems
VEEV
$33.5B
| $70.2M | 0.08% |
399,784
+27,635
| +7% | +$5.43M |
|
238
Realty Income
O
$59.2B
| $69.6M | 0.08% |
1,137,821
+112,957
| +11% | +$7.07M |
|
239
Array Technologies
ARRY
$872M
| $69.4M | 0.08% |
9,605,177
+1,673,168
| +21% | +$15.5M |
|
240
Williams-Sonoma
WSM
$28.2B
| $69.4M | 0.08% |
380,851
-140,163
| -27% | -$28M |
|
241
Broadridge
BR
$18.2B
| $69.4M | 0.08% |
427,072
+27,533
| +7% | +$5.23M |
|
242
Agilent Technologies
A
$39.5B
| $69.3M | 0.08% |
607,691
+126,891
| +26% | +$16.1M |
|
|
LGN
243
Legence Corp
LGN
$5.02B
| $68.6M | 0.08% |
1,214,823
+194,940
| +19% | +$9.82M |
|
244
ResMed
RMD
$31.2B
| $68.3M | 0.08% |
304,265
-18,572
| -6% | -$4.63M |
|
245
Ionis Pharmaceuticals
IONS
$9.06B
| $68.1M | 0.08% |
907,533
-445,304
| -33% | -$35.1M |
|
246
Baker Hughes
BKR
$60.4B
| $68M | 0.08% |
1,114,495
-107,713
| -9% | -$6.23M |
|
247
Sunrun
RUN
$2.49B
| $67.9M | 0.08% |
5,009,539
+2,131,755
| +74% | +$35.5M |
|
248
Coca-Cola Europacific Partners
CCEP
$47.8B
| $67.9M | 0.08% |
748,552
+133,594
| +22% | +$12.8M |
|
249
Otis Worldwide
OTIS
$27.5B
| $66.8M | 0.08% |
866,892
+102,136
| +13% | +$8.94M |
|
250
Payoneer
PAYO
$2.4B
| $66.3M | 0.08% |
13,734,583
-27,605
| -0.2% | -$146K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.